Does Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer? [ 2009 - 2012 ]

Research Grant

Researchers: Prof Michael Friedlander (Principal investigator) ,  Dr Mary Gainford ,  Dr Patrick Fitzgerald ,  Prof Amit Oza ,  Prof Madeleine King

Brief description This is a study in women who have relapsed ovarian cancer, and who are about to start further chemotherapy. Subjects will answer questions about their quality of life in order to measure any improvement in their symptoms and well being in response to palliative treatment. The study will relate subjects own reporting of improvement with their actual clinical response. The aim of this study is to develop an optimal palliative chemotherapy regime for use in future clinical trials.

Funding Amount $AUD 521,878.25

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant